S nake venom contains a toxic mixtures of enzymes, low molecular weight polypeptides, glycoproteins, and metal ions capable of causing local tissue damage as well as multiple-system failure (1) . The clinical manifestation of snake envenomation is usually progressive, from initial signs limited to the bitten area to systemic manifestations, occasionally severe enough to lead to rapid death from multiple-organ failure.
Myocardial damage following snakebite was observed following envenomation by different species of snakes (2) (3) (4) . Venom components can injure the heart via different mechanisms, among them direct cardiotoxicity (5), venom-induced coronary vasospasm or thrombosis (6, 7) , and myocardial hemorrhage (8) . Moreover, venom-induced hypotension was also shown to compromise coronary circulation, as manifested by electrocardiographic changes following the intravenous infusion of venom in a dog model of snake envenomation (7) .
It was recently suggested that the venom-inflicted tissue damage can be partially caused by tumor necrosis factor (TNF), which is processed to its active form by the injected venom metalloproteinases (9, 10) . In a previous study based on an in vivo model in rats, we demonstrated a systemic increase of serum TNF following snake envenomation. The TNF concentrations were detected 15 mins after venom injection and peaked after 2 hrs to a concentration of 485 Ϯ 18 pg/ mL. This increase of serum TNF was accompanied by a parallel significant deterioration in blood pressure that was effectively reversed by the administration of soluble TNF receptor (sTNF-R p55) and anti-TNF antibodies (11) .
The aim of the current study was to investigate whether the hemodynamic instability that was observed following venom injection is caused by a possible TNF-mediated cardiac toxicity. We used a Langendorff perfusion model of isolated rat heart following Vipera aspis envenomation.
MATERIALS AND METHODS

Experimental Protocol
All experiments were carried out in accordance with the guidelines established by the Institutional Animal Care and Use Committee at the Tel Aviv Medical Center and the University of Tel Aviv. Adult male Wistar rats weighing 300 -400 g were used.
The study protocol is described in Figure 1 . The study involved 40 rats divided equally into one control and three experimental groups (n ϭ 10 each). The control group was injected intramuscularly with 1 mL of 0.9% NaCl only. The three experimental groups were each injected intramuscularly with Vipera aspis venom 500 g/kg (1 mL in volume). Experimental groups 2 and 3 were given additional treatment as follows: an intramuscular injection of 250 g of sTNF-R p55 (1 mL in volume) 15 mins before the injection of venom (group 2), or an intraperitoneal injection of 40 g of anti-TNF antibodies (1 mL in volume) 60 mins before the injection of venom (group 3). Two hours following the envenomation, the rats were anesthetized by Objective: To investigate the possible role of tumor necrosis factor in mediating cardiotoxicity following venom injection in a rat.
Design: A randomized controlled experimental study using a Langendorff isolated heart model. KEY WORDS: snake envenomation; Vipera aspis; tumor necrosis factor antibodies; soluble tumor necrosis factor receptor p55; metalloproteinases intraperitoneal injection of pentobarbital sodium (60 mg/kg). Their hearts were rapidly excised, immersed in ice-cold saline, and mounted on a stainless steel cannula of a modified Langendorff perfusion apparatus (14) .
Retrograde aortic perfusion was initiated at a perfusion pressure of 85 mm Hg with an oxygenated modified Krebs-Henseleit buffer solution that had the following composition (mM): NaCl 118, KCl 4.7, CaCl 2.0, MgSO 4 7, H 2 O 1.2, KH 2 PO 4 1.2, glucose 11.1, and NaHCO 3 25. The perfusate was bubbled with 95% oxygen and 5% carbon dioxide, maintaining a pH of 7.4-7.5. The PO 2 and PCO 2 in the perfusion solution were 450 -550 mm Hg and 25-30 mm Hg, respectively.
The heart temperature was monitored by a thermistor placed in the right ventricular wall and maintained at 37°C. The right atrium was removed, and the heart was paced to 300 beats/min at 4 V by using an external pacemaker (Devices Limited, Implant Division type E4162), ensuring identical heart rates for all the experiments. A water-filled latex balloon was inserted into the left ventricular cavity through a small incision in the left atrium and connected to a pressure transducer (Mennen Medical PI) that was zeroed at diastolic pressure. Zero calibration of the pressure transducer was examined throughout the experiment.
The monitored measurements of cardiac function included left ventricular peak systolic pressure, time to peak systolic pressure, relaxation time, the first derivative of the rise and fall in left ventricular pressure (dP/dt max and dP/dt min ), the area calculated under the left ventricular developed pressure curve (pressure-time integral), which correlates with oxygen consumption (15) , and coronary flow. The coronary flow was calculated by using measurements of the perfusate dripping out from the coronary sinus as a function of time. These variables were continuously recorded and measurements were taken at 10-min intervals. After a 15-min period of stabilization (baseline), the experiment was continued for additional 60 mins.
Chemicals
TNF Antibodies. Polyclonal rabbit anti-rat TNF antibodies were purchased from Innogenetics (Antwerp, Belgium). Based on a previous study, the intraperitoneal route was used for the administration of the anti-rat TNF antibodies (12) .
Human Recombinant Soluble TNF Receptor. We used a dose of 250 g of human recombinant sTNF-R p55 per animal (a kind gift of the Weizman Institute, Israel). This choice was based on a previous study by our group in which sTNF-R p55 at doses of 200 and 300 g was given intramuscularly and found to attenuate septic manifestation in a rat model of bowel ischemia (13) .
RNA Isolation and Polymerase-Chain Reaction Amplification. Immediately after 1 hr of perfusion in the Langendorff apparatus, pieces of left ventricle myocardium were excised and kept at Ϫ70°C until analysis. Total RNA was extracted from the myocardial samples by using the guanidinium thiocyanate method (16) 
Two g of total RNA was subjected to reverse transcription reaction in 20 L by using a reverse transcription system (Promega, Madison, WI). After completion of the reaction, 5 L of this reaction mixture was used for TNF complementary DNA polymerase chain reaction (PCR) amplification, and 5 L of 1:10 diluted reaction mixture was used for GAPGH complementary DNA amplification. Our PCR negative control contained H 2 O instead of RNA. For TNF complementary DNA amplification, the following primers were used: sense, CACGTCTTCTGTCTACTGA;
antisense, GGAGCCATATTCATTGTCATA, producing a 546 base pair fragment (17) . An annealing temperature of 57°C was chosen for this reaction. For GAPGH complementary DNA amplification, the primers were as follows: sense, AATGCATCCTGCACCAA; antisense, GTAGC-CATATTCATTGTCATA, producing a 515 base pair fragment (18) . The annealing temperature here was 60°C. The optimal cycle number for the amplification of TNF was 30. For PCR amplification and reverse transcription reaction, a minicycler TM (MJ Research, Watertown, MA) was used.
Quantitative Analysis. PCR products (10 L) were separated in 1.8% agarose gel, stained with ethidium bromide, visualized by ultraviolet irradiation, and photographed with Polaroid film. Band densities on the film were evaluated by a Fujifilm Thermal Imaging System FTJ-500, computer-based image capture software (Amersham Pharmacia Biotech AB, Uppsala, Sweden), and the TINA program package (Raytest Isotope Messgerate, Pittsburgh, PA). Band intensities were expressed in arbitrary densitometry units. All TNF band intensities were normalized by respective GAPDH values. Each PCR reaction was repeated twice.
Histologic Assessment of the Myocardium. A portion of the left ventricle of the killed animals was placed in a 10% solution of formaldehyde for standard fixation. Microthin sections were taken and stained with hematoxylin and eosin for light microscopic analysis. The pathologist who analyzed the microscopic sections was blinded to the protocol.
Statistics. Results are reported as a mean Ϯ SE. The measurements in the coronary effluent were normalized to grams of dry heart weight. The measurements taken at 10-min intervals were subjected to analysis of variance with repeated measures. Multiple comparisons were performed by using the Dunnett procedure (control with each of the three experimental groups). Contrast analysis was performed to compare between successive time points. We considered p Ͻ .05 to be significant. Figure 1 . The time scale, in minutes, of the experimental protocol. The time and the route of administration of the anti-tumor necrosis factor (TNF) antibodies and soluble TNF receptor (sTNF-R p55) were chosen based on previously described pharmacokinetics of the two agents (12, 13) . A 2-hr period was allowed for absorption and systemic spread of the venom, after which the hearts were excised and cardiac functions were measured over 60 mins.
RESULTS
Cardiac Performances of the Isolated Hearts
All baseline variables of cardiac performances that were taken 15 mins after stabilization were statistically reduced following the venom injection in experimental group 1 compared with the control group. However, the other two experimental groups (sTNF-R p55 and anti-TNF antibodies) were not significantly different from the control group (Table 1) .
Throughout the first 30 mins of the experiment, the cardiac function of the venom-only-treated animals (group 1) continued to deteriorate at each measurement point and was significantly worse than the control group (Fig. 2) . All the hemodynamic variables exhibited a similar and parallel trend of change during the 60 mins of the experiment (Fig.  2) . A maximal depression of the variables of cardiac performance was observed 30 mins after we placed the isolated hearts on the Langendorff apparatus: peak systolic pressure (mm Hg) 38 Ϯ 4, dP/dt max (mm Hg/sec) 1252 Ϯ 116, dP/dt mim (mm Hg/sec) Ϫ1054 Ϯ 98, time-pressure integral (mm Hg/sec) 2 Ϯ 0.2, and coronary flow (mL/min) 6.8 Ϯ 1.4. Some improvement in cardiac function was observed in the venom-only-injected group in the last measurements (i.e., 50 and 60 mins), although at no point did the mechanical variables return to baseline.
The venom-induced cardiac depression was significantly attenuated by pretreatment with either sTNF-R p55 or anti-TNF antibodies (Table 1 and Fig. 2 ).
Myocardial TNF RNA Measurements and Histologic Assessment
No increase in TNF RNA concentrations was detected in the myocardial tissue of the control and the venom-onlyinjected rats. In addition, no histologic changes were observed in the treated groups compared with the control group.
DISCUSSION
We observed a significant depression of myocardial performances of isolated rat hearts that had been envenomated by an intramuscular injection of Vipera aspis venom. The cardiodepressive effects were attenuated by the preenvenomation administration of sTNF-R p55 or anti-TNF antibodies, both known to ameliorate the adverse effects of TNF on cell function (15, 19) .
The cardiodepressive effects in the venom-injected groups are compatible with the known cardiotoxicity of snake venom in rat as well as in human hearts (20, 21) . Since no detectable concentrations of TNF-RNA were measured in this model of an isolated rat heart, we postulate that a systemic rather than local release of TNF is responsible for the observed cardiotoxicity following venom injection.
The p55 receptor is the main receptor that mediates TNF signaling to the cells. The p55-R and p75-R receptors exist in soluble forms and are probably derived by proteolytic cleavage from the cell surface. These soluble receptors can compete for TNF with the cell surface receptors and thus block its bioavailability, attenuating its activity and potential harmful effects (15, 19, 22) . The myocardial depression caused by the venom was attenuated by pretreating the animals with sTNF-R p55. In a similar way, the deleterious effects of the venom to the heart were reduced by pretreatment with anti-TNF antibodies. Although a potential direct effect of the venom on the myocardial function is possible, this is unlikely since both anti-TNF antibodies and sTNF-R p55 minimized the venom-induced cardiotoxicity, indicating that TNF is potentially responsible for the observed hemodynamic alterations.
Indeed, in a recent report of 18 children bitten by snakes of the Viperidae family in Costa Rica, Avila-Aguero et al. (23) found increased serum concentrations of interleukin-6, interleukin-8, and TNF-␣ in all their patients. In this report, TNF-␣ concentrations peaked to a mean of 48 pg/mL 12 hrs after the envenomation. Other animal and humans studies report apparent local generation of TNF that results in only regional necrosis and not in systemic consequences (24, 25) .
Our results support the role of TNF as a key mediator in venom-induced cardiotoxicity. This observation is in agreement with a previous report by us of the cardiodepressive effect of TNF when using a similar model of an isolated heart undergoing ischemia and reperfusion (26, 27) . Other potential mechanisms, however, have been described as well. Snake envenomation can cause severe muscular damage resulting in extensive rhabdomyolysis (28) . Indeed, myotoxic components of snake venom capable of causing myocardial as well as striated muscle damage have been isolated from snake venom (29 -31) . These myocardial changes were not detected by light microscopy, similar to our observation, but rather by electron microscopy only.
We observed a 50% reduction in coronary blood flow in our venom-treated rats. These findings are in agreement with a report by Tibballs et al. (7) , who concluded that this phenomenon was secondary to disseminated intravascular coagulation and the generation of microscopic thrombi in the coronary artery.
In our previous study, we demonstrated the role of TNF as an important mediator in causing hemodynamic deterioration following snakebite (11) . Several mechanisms may have been re- Venom, Vipera aspis 500 g/kg; sTNF-R p55 soluble tumor nichosis factor receptor (250 g); anti-TNF AB, anti-TNF antibodies (40 g); dP/dt, change in pressure over time.
Comparisons were made between control and each of the experimental groups by using data measured 15 min after stabilization. All cardiac variables of the venom-only group were statistically reduced compared with the control group. a p Ͻ .05.
sponsible for this venom-induced hemodynamic instability. The results of the current study further clarify the role of TNF in the pathophysiology of the hemodynamic changes following snakebite.
CONCLUSION
An intramuscular injection of Vipera aspis venom can cause cardiac depression, which is probably mediated by systemic TNF release. Because these deleterious effects were attenuated by a blockade of TNF activity, further investigation of the role of TNF as a mediator of venom toxicity is warranted. 
